Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL140979 (JTC-801) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
δ receptor/Delta opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL236] [GtoPdb: 317] [UniProtKB: P41143] | ||||||||
ChEMBL | Inhibition of [3H]naltrindole (0.55 nM) binding from human Opioid receptor delta 1 expressed in CHO-K1 cells. | B | 5.06 | pKi | 8647.2 | nM | Ki | J Med Chem (2000) 43: 4667-4677 [PMID:11101358] |
ChEMBL | Binding affinity for opioid receptor type, human Opioid receptor delta 1 expressed in membrane homogenates of COS-1 or CHO cells | B | 5.06 | pKi | 8647 | nM | Ki | J Med Chem (2002) 45: 5353-5357 [PMID:12431062] |
histone deacetylase 6/Histone deacetylase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1865] [GtoPdb: 2618] [UniProtKB: Q9UBN7] | ||||||||
ChEMBL | Determination of IC50 values for inhibition of enzymatic assay of human HDAC6 with custom peptide substrate | B | 5.46 | pIC50 | 3486 | nM | IC50 | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
κ receptor/Kappa opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL237] [GtoPdb: 318] [UniProtKB: P41145] | ||||||||
ChEMBL | Inhibition of [3H]naltrindole (0.55 nM) binding from human Opioid receptor kappa 1 | B | 5.98 | pKi | 1057.5 | nM | Ki | J Med Chem (2000) 43: 4667-4677 [PMID:11101358] |
ChEMBL | Binding affinity for opioid receptor type, human Opioid receptor kappa 1 expressed in membrane homogenates of COS-1 or CHO cells | B | 5.98 | pKi | 1057 | nM | Ki | J Med Chem (2002) 45: 5353-5357 [PMID:12431062] |
ChEMBL | Displacement of [3H]-naltrindole from human kappa opioid receptor expressed in human HEK293 cells after 2 hrs by scintillation counting | B | 5.12 | pIC50 | 7512 | nM | IC50 | Eur J Med Chem (2011) 46: 1207-1221 [PMID:21330016] |
μ receptor/Mu opioid receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL233] [GtoPdb: 319] [UniProtKB: P35372] | ||||||||
ChEMBL | Inhibition of [3H]diprenorphine (0.33 nM) binding from human Opioid receptor mu 1 expressed in CHO-K1 cells. | B | 6.99 | pKi | 102.9 | nM | Ki | J Med Chem (2000) 43: 4667-4677 [PMID:11101358] |
ChEMBL | Binding affinity for opioid receptor type, human Opioid receptor mu 1 expressed in membrane homogenates of COS-1 or CHO cells | B | 6.99 | pKi | 102 | nM | Ki | J Med Chem (2002) 45: 5353-5357 [PMID:12431062] |
ChEMBL | Displacement of [3H]-naltrindole from human mu opioid receptor expressed in CHO cells after 2 hrs by scintillation counting | B | 5.82 | pIC50 | 1507 | nM | IC50 | Eur J Med Chem (2011) 46: 1207-1221 [PMID:21330016] |
NOP receptor/Nociceptin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2014] [GtoPdb: 320] [UniProtKB: P41146] | ||||||||
ChEMBL | Binding affinity for opioid receptor like type, human Opioid receptor like 1 expressed in membrane homogenates of COS-1 or CHO cells | B | 8.09 | pKi | 8.2 | nM | Ki | J Med Chem (2002) 45: 5353-5357 [PMID:12431062] |
ChEMBL | Ability to displace [3H]nociceptin ( 0.5 nM ) binding from Opioid receptor like 1 expressed in HeLa cells. | B | 8.09 | pKi | 8.2 | nM | Ki | J Med Chem (2000) 43: 4667-4677 [PMID:11101358] |
GtoPdb | - | - | 8.1 | pKi | - | - | - | J Med Chem (2000) 43: 4667-77 [PMID:11101358] |
ChEMBL | Displacement of [125I]Tyr14-nociceptin from human NOP receptor expressed in human HEK293 cells after 2 hrs by scintillation counting | B | 7.52 | pIC50 | 30 | nM | IC50 | Eur J Med Chem (2011) 46: 1207-1221 [PMID:21330016] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]